| Concept | Preferred term / definition | Common synonyms / legacy names | ICD-10 / coding | ICD-11 / AUD note | NHANES prevalence under 2023 SLD nomenclature | Notes (URL; publication date) |
|---|---|---|---|---|---|---|
| Disease entity | **Alcohol-associated liver disease (ALD)** is the current preferred term in recent hepatology literature; within the 2023 steatotic liver disease (SLD) framework, ALD is a subclass of SLD distinct from MASLD and MetALD (pqac-00000001, pqac-00000009, pqac-00000013) | Alcoholic liver disease; alcohol-related liver disease; ArLD; ALD (legacy and regional usage varies) (pqac-00000000, pqac-00000001, pqac-00000013) | ICD-10 alcoholic liver disease code family **K70.***; examples cited in available sources include **K70.0–K70.4, K70.9** (pqac-00000008, pqac-00000012) | Expert consensus paper notes ICD-11 criteria for alcohol dependence/AUD require **2 or more of 3 symptoms**; used as clinical context rather than liver-disease code mapping (pqac-00000009) | Not a prevalence row by itself | Alvarado-Tapias et al. 2024: https://doi.org/10.3350/cmh.2024.0709 ; Oct 2024. Lee et al. 2024 consensus statement: https://doi.org/10.1038/s41575-024-00936-x ; Jun 2024. |
| SLD umbrella term | **Steatotic liver disease (SLD)** is the umbrella nomenclature adopted by multisociety consensus, encompassing MASLD, MetALD, ALD, and etiology-specific/cryptogenic SLD (pqac-00000010, pqac-00000013) | Fatty liver disease spectrum (legacy framing) (pqac-00000009, pqac-00000013) | No specific ICD-10 range provided in available evidence for SLD umbrella term | Delphi consensus on future ICD harmonization for SLD published, but no explicit ICD-11 liver-code mapping provided in available evidence (pqac-00000009) | **34.2%** (95% CI **31.9%–36.5%**) (pqac-00000010) | Lee et al. 2024 NHANES analysis: https://doi.org/10.1097/hep.0000000000000604 ; Sep 2024. |
| Metabolic subclass | **Metabolic dysfunction-associated steatotic liver disease (MASLD)** (pqac-00000009, pqac-00000010) | NAFLD showed ~99% overlap with MASLD in NHANES analysis (pqac-00000010) | No specific ICD-10 range provided in available evidence | In trial-consensus context, alcohol thresholds help distinguish MASLD from MetALD/ALD (pqac-00000009) | **31.3%** (95% CI **29.2%–33.4%**) (pqac-00000010) | Lee et al. 2024 NHANES analysis: https://doi.org/10.1097/hep.0000000000000604 ; Sep 2024. |
| Overlap subclass | **MetALD** = MASLD plus increased alcohol intake; consensus thresholds cited as women **140–350 g/week** and men **210–420 g/week** in one expert statement (pqac-00000009) | Metabolic dysfunction- and alcohol-associated liver disease; metabolic and alcohol-associated liver disease (pqac-00000013) | No specific ICD-10 range provided in available evidence | Relevant as a nomenclature and trial-stratification category rather than a distinct ICD-11 code in available evidence (pqac-00000009) | **2.0%** (95% CI **1.6%–2.9%**) (pqac-00000010) | Lee et al. 2024 NHANES analysis: https://doi.org/10.1097/hep.0000000000000604 ; Sep 2024. Lee et al. 2024 consensus statement: https://doi.org/10.1038/s41575-024-00936-x ; Jun 2024. |
| Alcohol subclass | **ALD** within SLD nomenclature; Delphi/expert statement defined ALD as alcohol consumption exceeding **420 g/week (men)** or **350 g/week (women)**, with or without cardiometabolic risk factors (pqac-00000009) | Alcohol-associated liver disease; alcoholic liver disease; alcohol-related liver disease (pqac-00000000, pqac-00000001, pqac-00000013) | ICD-10 **K70.*** family applies to alcoholic liver disease diagnoses in administrative coding (pqac-00000008, pqac-00000012) | ICD-11 AUD/dependence criteria mentioned in consensus/trial-design paper; no explicit ICD-11 ALD code supplied in available evidence (pqac-00000009) | **0.7%** (95% CI **0.5%–0.9%**) (pqac-00000010) | Lee et al. 2024 NHANES analysis: https://doi.org/10.1097/hep.0000000000000604 ; Sep 2024. Manthey et al. 2025 ICD-10 EHR usage: https://doi.org/10.1186/s13011-025-00670-w ; Sep 2025. |
| Administrative/EHR coding note | In EHR work, severe alcohol-related disease burden category explicitly included alcoholic liver disease diagnoses | Alcoholic liver cirrhosis and related alcohol-specific organ disease codes in EHR severity work (pqac-00000008) | **K70; K70.0–K70.4; K70.9** specifically listed in available evidence (pqac-00000008, pqac-00000012) | ICD-10 was the basis of the cited EHR classification; authors note different jurisdictions may use ICD-11, but mapping not provided here (pqac-00000008) | Not applicable | Manthey et al. 2025: https://doi.org/10.1186/s13011-025-00670-w ; Sep 2025. Hagström et al. 2024 ICD consensus: https://doi.org/10.1097/hc9.0000000000000386 ; Feb 2024. |


*Table: This table summarizes current naming conventions, coding references, and U.S. NHANES prevalence estimates relevant to Alcoholic Liver Disease / Alcohol-associated liver disease within the 2023 steatotic liver disease framework. It is useful for aligning legacy terminology, ICD coding, and modern subclassification terms in a disease knowledge base.*